Anjarium Biosciences Company

Anjarium Biosciences is a company that is developing a new type of non-viral gene therapy to treat genetic diseases. They are using bioinspired nanomedicine to address a range of genetic diseases, including those that require large gene delivery. Their platform aims to provide benefits to patients that have previously been out of reach by addressing key deficiencies of viral gene therapies. Anjarium Biosciences is pioneering the next generation of non-viral gene therapy by targeting more diseases, more precisely, and in a more personalized way.


Estimated Revenue: $105M. When
Headquarters: Schlieren
Total Funding: $60.4M
Founded Date: 2017
Technology: Gene Therapy
Industry: BioTech
Employee Number: 1-10